GLUE•benzinga•
Monte Rosa Therapeutics Plans To Initiate Phase 1 Study Of MRT-8102 In Coming Weeks And Anticipates Sharing Initial Results In H1 2026
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 10, 2025 by benzinga